MS News That Caught My Eye: Kesimpta, Ocrevus and Chickenpox...
multiplesclerosisnewstoday.com
Columnist Ed Tobias discusses the week's top MS news, including FDA approval of Kesimpta (ofatumumab), a self-administered treatment.